The Latest in HCV Hub

Shortening all-oral HCV therapy feasible

May 14, 2015

ILC: Direct antivirals safely clear HCV despite ESRD

May 14, 2015

ILC: Europe issues hepatitis C treatment priority list

May 12, 2015

ILC: HCV treatment delays dented efficacy in era before all-oral therapy

May 10, 2015

HCV spike in four Appalachian states tied to drug abuse

May 10, 2015

ILC: Real-world success for all-oral antiviral therapy in HCV-related cirrhosis

May 9, 2015

Consider HCV ‘a cardiovascular risk factor’

May 5, 2015

Interferon-free antiviral regimens achieve high response rates in HCV

May 5, 2015

ILC: Statins linked to better outcomes in hepatitis C cirrhosis

May 3, 2015

HCV increases general cancer risk

April 27, 2015

ILC: Unrecognized hepatitis C linked with advanced hepatic fibrosis

April 27, 2015

ILC: New single daily pill eradicates hepatitis C

April 25, 2015

Indiana HIV outbreak prompts national advisory

April 24, 2015

FDA adds warnings to simeprevir label

April 16, 2015

Antihistamine drug chlorcyclizine shows promise for treating HCV

April 8, 2015